Metformin Sandoz 500 mg is a highly effective oral hypoglycemic agent and a cornerstone in the pharmacological management of Type 2 Diabetes Mellitus. As a biguanide, it is specifically indicated for patients whose blood glucose levels remain uncontrolled despite rigorous adherence to diet and physical activity. It is the preferred first-line preparation for adult patients with excess body weight, as it helps reduce macrovascular and microvascular complications. Metformin Sandoz can be utilized as a standalone monotherapy or integrated into complex treatment regimens alongside other oral antidiabetics or insulin, catering to both adults and pediatric populations from the age of 10.
Each film-coated tablet is meticulously formulated for therapeutic consistency:
Active Substance: Metformin hydrochloride — 500 mg.
Excipients: Povidone, magnesium stearate.
Film Coating: Hypromellose, titanium dioxide (E 171), and macrogol 4000.
Metformin Sandoz targets hyperglycemia through a multi-faceted biological approach that does not trigger excessive insulin secretion:
Hepatic Control: It significantly decreases hepatic glucose production by inhibiting the processes of gluconeogenesis and glycogenolysis.
Cellular Sensitivity: It enhances the sensitivity of peripheral tissues (especially skeletal muscle) to insulin, facilitating improved glucose uptake and disposal.
Absorption Modulation: It delays the absorption of glucose from the intestinal tract.
Unlike sulfonylureas, metformin does not cause weight gain and has a minimal risk of hypoglycemia when used alone. It also exerts a positive influence on lipid metabolism, helping to maintain healthy cholesterol levels.
Type 2 Diabetes Mellitus: Management in adults and children/adolescents (10+ years).
First-line Therapy: Ideal for overweight patients to minimize long-term diabetic complications.
Combination Therapy: Compatible with insulin or other oral hypoglycemic agents for synergistic glycemic control.
Hypersensitivity to metformin or any tablet components.
Metabolic Acidosis: Any acute form, including lactic acidosis or diabetic ketoacidosis.
Severe Renal Impairment: Glomerular filtration rate (GFR) < 30 ml/min.
Hypoxia-inducing Conditions: Decompensated heart failure, respiratory failure, or recent myocardial infarction.
Acute Risks: Severe dehydration, shock, or severe infectious diseases.
Liver Health: Liver failure, acute alcohol poisoning, or chronic alcoholism.
Adult Patients:
Initial Dose: Usually 500 mg taken 2–3 times daily.
Titration: After 10–15 days, adjust the dose based on blood serum glucose measurements.
Maximum Dose: 3000 mg per day, divided into 3 doses.
Switching: When transitioning from another antidiabetic agent, stop the previous medication before starting Metformin Sandoz.
Children and Adolescents (10+ Years):
Regimen: Monotherapy or combined with insulin. The initial dose and titration follow the adult protocol, ensuring slow increases to protect the digestive tract.
Meal Coordination: Take tablets during or after meals to prevent stomach upset.
Elderly Patients: Dosage should be carefully adjusted based on regular renal function assessments.
Gastrointestinal (Very Frequent): Nausea, vomiting, diarrhea, flatulence, abdominal pain, and lack of appetite. These usually occur at the start and fade spontaneously.
Nervous System (Frequent): Changes in taste (metallic sensation).
Metabolic (Rare): Lactic acidosis. Long-term use may lead to Vitamin B12 deficiency (megaloblastic anemia).
Hepatobiliary: Isolated cases of impaired liver function tests or hepatitis.
Lactic Acidosis: A rare but life-threatening emergency. If symptoms like muscle cramps or severe weakness occur, stop the drug and seek immediate hospitalization.
Pregnancy: While data is limited, insulin is typically recommended during pregnancy to maintain the strictest possible glucose control.
Breastfeeding: Not recommended due to metformin being excreted in breast milk and insufficient safety data.
Driving: Monotherapy is safe; however, risks of hypoglycemia arise when combined with sulfonylureas, insulin, or meglitinides.
No special temperature storage conditions are required, but it is best kept in a cool, dry place.
Ensure the medication is kept in its original packaging and out of the reach of children.
Shelf Life: Refer to the expiration date on the package.
There are no reviews for this product.